LFD results from structural airway changes that accompany underlying airway inflammation in asthma patients with severe asthma may experience accelerated LFD.
#Free clinical trials for copd current nc trial#
Contacts:Īssessing long- Term Lung function decline with dupilum Ab in a Sthma ( ATLAS) Clinical Trial Description:Īsthma is a chronic inflammatory disease, characterized by variable and reversible airflow obstruction that may involve lung function decline (LFD) over time.
![free clinical trials for copd current nc free clinical trials for copd current nc](https://erj.ersjournals.com/content/erj/56/1/2000627/F2.large.jpg)
This clinical research study is for adults age 18 to 85 with a clinical history consistent with NCFBE that is confirmed by chest computerized tomography scan, and a history of at least 2 pulmonary exacerbations in the prior 12 months. The study will enroll approximately 1620 individuals with NCFBE in at approximately 480 study centers globally. Insmed Incorporated Clinical Trial Title:Ī Phase 3, Randomized, Double blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects With Non-Cystic Fibrosis Bronchiectasis - The ASPEN Study Clinical Trial Description:ĪSPEN is a clinical research study for adults with a clinical diagnosis of non-cystic fibrosis bronchiectasis (NCFBE) to evaluate an investigational study drug (brensocatib). Insmed Medical Information 844-4-INSMED Date Posted: These clinical research studies are for adults age 18 and older with a current diagnosis of Mycobacterium avium Complex (MAC) lung infection.
#Free clinical trials for copd current nc mac#
Eligible patients will be assigned to one of these two studies that together will enroll approximately 350 individuals with MAC lung infection in at approximately 150 study centers globally. Insmed Incorporated Clinical Trial Titles:ĪRISE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)ĮNCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC) Clinical Trial Description:ĪRISE and ENCORE are parallel clinical research studies for adults with a recent diagnosis of Mycobacterial avium complex (MAC) lung infection to evaluate an inhaled investigational study drug (amikacin liposome inhalation suspension).
![free clinical trials for copd current nc free clinical trials for copd current nc](https://admin.lidsen.com/uploads/specialImgs/2020-11-19/5fb62e9013c4e.jpg)
Trials in Interstitial Lung Disease (ILD) Trials in Idiopathic Pulmonary Fibrosis (IPF) Trials in Hypereosinophilic Syndrome (HES)
![free clinical trials for copd current nc free clinical trials for copd current nc](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1465-9921-10-29/MediaObjects/12931_2009_743_Fig1_HTML.jpg)
Trials in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
![free clinical trials for copd current nc free clinical trials for copd current nc](https://ascpt.onlinelibrary.wiley.com/cms/asset/6ef453a5-82c2-4e51-a7cb-3785539180d3/cpt1540-fig-0001-m.jpg)
If your company is not a current ATS Corporate Member and you would like to see your company’s trials listed, please contact Vlada Kagan O'Hara at in Allergic Bronchopulmonary Aspergillosis (ABPA) If you would like to receive information about new clinical trials listed on this page, please email us to join the Clinical Trial Listserve.Ĭompanies that are ATS Corporate Members at the Supporter Level or higher can list clinical trials at no charge as part of member benefits. A complete US Clinical Trial listing can be found at. The ATS does not endorse any trial listed, however we hope the below trial opportunities will be a valuable resource to clinicians, patients, and researchers in the combined goal of improving and advancing patient care. Welcome to our Clinical Trial Resources page connecting the ATS community to current, ongoing clinical trials in pulmonary, critical care, and sleep medicine being conducted by participating pharmaceutical and device companies.